Show simple item record

FieldValueLanguage
dc.contributor.authorDegeling, C
dc.contributor.authorCarter, SM
dc.contributor.authorRychetnik, L
dc.date.accessioned2016-08-10
dc.date.available2016-08-10
dc.date.issued2016-08-03
dc.identifier.citationDegeling C., Carter SM., Rychetnik L., All care, but whose responsibility? Community juries reason about expert and patient responsibilities in prostate-specific antigen screening for prostate cancer, Health · August 2016, DOI: 10.1177/1363459316660862, http://hea.sagepub.com/content/early/2016/07/29/1363459316660862en_AU
dc.identifier.urihttp://hdl.handle.net/2123/15500
dc.descriptionpostprinten_AU
dc.description.abstractGeneral practitioners have implicitly been given responsibility for guiding men’s decisions about prostate-specific antigen–based screening for prostate cancer, but patients’ expectations of the bounds of this responsibility remain unclear. We sought to explore how well-informed members of the public allocate responsibilities in prostate-specific antigen screening decision-making. In 2014, we convened two Community juries in Sydney, Australia, to address questions related to the content and timing of information provision and respective roles of patients and general practitioners in screening decisions. Participants in the first jury were of mixed gender and of all ages (n = 15); the participants in the second jury were all male and of screening age (n = 12). Both juries were presented with balanced factual evidence on the harms and benefits of prostate-specific antigen screening and expert perspectives on ethico-legal aspects of consent in medical practice. In their deliberations, jurors agreed that general practitioners should take responsibility for informing men of the options, risks and benefits of prostate-specific antigen testing, but arrived at different positions on whether or not general practitioners should also guide screening decisions. Jurors also disagreed on how much and when general practitioners should provide detailed information about biopsies and treatments. These responses suggest that for prostate-specific antigen testing, there is a public expectation that both the allocation of responsibility between general practitioners and their male patients, and the level of information provided will be tailored to individual men. In the presence of expert uncertainty, a well-informed public may have reason to embrace or resist shared decision-making processes. bioethics cancer and palliative care organisation of health services patient–physician relationship risk and healthen_AU
dc.description.sponsorshipThis work was supported by the National Health and Medical Research Council of Australia [GNT 1023197].en_AU
dc.language.isoenen_AU
dc.publisherSageen_AU
dc.subjectbioethicsen_AU
dc.subjectcancer and palliative careen_AU
dc.subjectorganisation of health servicesen_AU
dc.subjectrisk and healthen_AU
dc.subjectpatient–physician relationshipen_AU
dc.titleAll care, but whose responsibility? Community juries reason about expert and patient responsibilities in prostate-specific antigen screening for prostate canceren_AU
dc.typeArticleen_AU
dc.identifier.doi10.1177/1363459316660862


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.